Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Preventive Treatment During Pregnancy in Benin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Pregnancy between 16 and 28 weeks of gestation~* Residence near the maternity clinics~* Intention to continue the ante-natal care and deliver at the study maternity clinic~* Ability to take drugs by oral route~* Written informed consent (parents or guardian if aged \< 18 years)~Exclusion Criteria:~* Pregnancy prior to 16 weeks or after 28 weeks of gestation~* Previous suspected reaction to sulfadoxine-pyrimethamine or mefloquine~* History of neurological or psychiatric event~* Intake of sulfadoxine-pyrimethamine or mefloquine within 4 weeks of enrollment~* Current treatment with halofantrine

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).